From Phosphaturia to Cardiovascular Protection: Is FGF-23 the Heart of the Matter?

Tekijä Toto, Robert D.
Julkaisussa Circulation (2015)

Transplantation: The role of RAAS blockade in kidney transplantation

Tekijä Toto, Robert D.
Julkaisussa Nat Rev Nephrol (2015)

Serum Potassium and Cardiovascular Outcomes: The Highs and the Lows

Tekijä Toto, Robert D.
Julkaisussa Clin J Am Soc Nephrol (2017)

Aldosterone Blockade in chronic Kidney Disease: Can it Improve Outcome?

Tekijä Toto, Robert D.
Julkaisussa Curr Opin Nephrol Hypertens (2010)

Bardoxolone—the Phoenix?

Tekijä Toto, Robert D.
Julkaisussa J Am Soc Nephrol (2018)

Defining Hypertension: Role of New Trials and Guidelines

Tekijä Toto, Robert D.
Julkaisussa Clin J Am Soc Nephrol (2018)

Management of Hypertensive Chronic Kidney Disease: Role of Calcium Channel Blockers

Tekijä Toto, Robert D.
Julkaisussa J Clin Hypertens (Greenwich) (2007)

Microalbuminuria: Definition, Detection, and Clinical Significance

Tekijä Toto, Robert D.
Julkaisussa J Clin Hypertens (Greenwich) (2007)

Reducing Cardiovascular Events in High‐Risk Patients: The Challenge of Managing Hypertension in Patients With Diabetic Renal Disease

Tekijä Toto, Robert D.
Julkaisussa J Clin Hypertens (Greenwich) (2007)

Anemia, Diabetes, and Chronic Kidney Disease

Tekijä Mehdi, Uzma, Toto, Robert D.
Julkaistu 2009

Is Choice of Antihypertensive Agent Important in Improving Cardiovascular Outcomes in High-Risk Hypertensive Patients?

Tekijä Inrig, Jula K., Toto, Robert D
Julkaisussa Am J Kidney Dis (2009)

Effect of losartan and spironolactone on triglyceride-rich lipoproteins in diabetic nephropathy

Tekijä Srivastava, Anand, Adams-Huet, Beverley, Vega, Gloria L, Toto, Robert D
Julkaisussa J Investig Med (2016)

Association of Blood Pressure Increases During Hemodialysis With 2-Year Mortality in Incident Hemodialysis Patients: A Secondary Analysis of the Dialysis Morbidity and Mortality Wa...

Tekijä Inrig, Jula K., Patel, Uptal D., Toto, Robert D., Szczech, Lynda A.
Julkaistu 2009

Prevalence of Major Depressive Episode in CKD

Tekijä Hedayati, S. Susan, Minhajuddin, Abu T., Toto, Robert D., Morris, David W., Rush, A. John
Julkaistu 2009

Validation of Depression Screening Scales in Patients With CKD

Tekijä Hedayati, S. Susan, Minhajuddin, Abu T., Toto, Robert D., Morris, David W., Rush, A. John
Julkaistu 2009

Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy

Tekijä Mehdi, Uzma F., Adams-Huet, Beverley, Raskin, Philip, Vega, Gloria L., Toto, Robert D.
Julkaistu 2009

Potassium Handling with Dual Renin-Angiotensin System Inhibition in Diabetic Nephropathy

Tekijä Van Buren, Peter N., Adams-Huet, Beverley, Nguyen, Mark, Molina, Christopher, Toto, Robert D.
Julkaistu 2014

Managing Hypertension in Patients with CKD: A Marathon, Not a SPRINT

Tekijä Chertow, Glenn M., Beddhu, Srinivasan, Lewis, Julia B., Toto, Robert D., Cheung, Alfred K.
Julkaisussa J Am Soc Nephrol (2016)

Patiromer and maintenance of RAASi therapy in hyperkalemic medicare patients

Tekijä Desai, Nihar R., Rowan, Christopher G., Alvarez, Paula J., Fogli, Jeanene, Toto, Robert D.
Julkaisussa J Drug Assess (2019)

Hyperkalemia treatment modalities: A descriptive observational study focused on medication and healthcare resource utilization

Tekijä Desai, Nihar R., Rowan, Christopher G., Alvarez, Paula J., Fogli, Jeanene, Toto, Robert D.
Julkaisussa PLoS One (2020)